Table 1.
Baseline demographic and clinical characteristics of MS patients
| Patients with vitamin D deficiency | Patients with normal vitamin D | Total | p | |
|---|---|---|---|---|
| Age (mean ± SD) | 37.91 ± 9.94 | 34.00 ± 8.12 | 37.52 ± 9.82 | 0.151 |
| Gender (n, %) | ||||
| Women | 97 (72.4) | 10 (66.7) | 107 (71.8) | 0.642 |
| Men | 37 (27.6) | 5 (33.3) | 42 (28.2) | |
| BMI (mean ± SD) | 24.76 ± 4.66 | 24.33 ± 3.81 | 24.72 ± 4.57 | 0.692 |
|
Disease duration (year) (median, IQR) |
5.0 (7.0) | 3.0 (7.0) | 5.0 (7.0) | 0.730 |
| EDSS (median, IQR) | 1.50 (8.5) | 1.25 (6)] | 1.50 (8.5) | 0.830 |
| Vitamin D level (ng/mL) (mean ± SD) | 13.12 ± 7.52 | 38.73 ± 13.16 | 15.70 ± 11.27 | < 0.001 |
| MSQOLI0 (mean ± SD) | 74.89 ± 20.41 | 78.00 ± 20.97 | 75.20 ± 20.42 | 0.555 |
| FSS0 (mean ± SD) | 36.02 ± 18.19 | 34.80 ± 20.68 | 35.90 ± 18.38 | 0.740 |
Bold-italicized numbers in the table (P < 0.05) was chosen as the minimum level of statistical significance